切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2025, Vol. 14 ›› Issue (03) : 442 -448. doi: 10.3877/cma.j.issn.2095-3232.2025.03.017

临床研究

胰腺癌动脉受侵的类型及手术策略研究
刘翔1, 刘军桂2, 张涛3, 金奎2, 郭宇2, 雷磊2, 段伟宏2,()   
  1. 1. 102200 北京京都儿童医院肿瘤外科
    2. 100088 北京,火箭军特色医学中心科室肝胆外科
    3. 100036 北京,中国人民解放军总医院肝胆胰外科医学部
  • 收稿日期:2024-10-10 出版日期:2025-06-10
  • 通信作者: 段伟宏

Study on classification for arterial invasion of pancreatic cancer and its surgical strategies

Xiang Liu1, Jungui Liu2, Tao Zhang3, Kui Jin2, Yu Guo2, Lei Lei2, Weihong Duan2,()   

  1. 1. Department of Surgical Oncology,Beijing Jingdu Children's Hospital,Beijing 102200,China
    2. Department of Hepatobiliary Surgery,PLA Rocket Force Characteristic Medical Center,Beijing 100088,China
    3. Department of Hepatobiliary and Pancreatic Surgery,Chinese PLA General Hospital,Beijing 100036,China
  • Received:2024-10-10 Published:2025-06-10
  • Corresponding author: Weihong Duan
引用本文:

刘翔, 刘军桂, 张涛, 金奎, 郭宇, 雷磊, 段伟宏. 胰腺癌动脉受侵的类型及手术策略研究[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 442-448.

Xiang Liu, Jungui Liu, Tao Zhang, Kui Jin, Yu Guo, Lei Lei, Weihong Duan. Study on classification for arterial invasion of pancreatic cancer and its surgical strategies[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(03): 442-448.

目的

探索胰腺癌动脉受侵的类型及手术策略。

方法

回顾性分析2021年7月至2024年5月中国人民解放军火箭军特色医学中心收治的17例胰腺癌局部晚期患者的临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男9例,女8例;年龄47~71岁,中位年龄61岁。胰腺中低分化腺癌13例,胰腺腺鳞癌2例,胰腺导管腺癌1例,壶腹部腺癌(胰胆管型)1例。肿瘤同时侵犯门静脉-肠系膜上静脉及肠系膜上动脉患者10例,侵犯门静脉-肠系膜上静脉及肝总动脉3例,侵犯门静脉-肠系膜上静脉及肝固有动脉2例,侵犯门静脉-肠系膜上静脉及腹腔干2例。根据动脉受侵部位分为Ⅰ、Ⅱ、Ⅲ型,每个分型再分为不同亚型,观察术中、并发症及术后恢复等围手术期情况。

结果

17例患者手术顺利实施。根据胰腺癌动脉受侵不同类型采用不同手术方式,其中Ⅰ型7例(Ⅰa型3例,Ⅰb型3例、Ⅰd型1例),Ⅱ型10例。术中出血量500~3 600 ml,中位出血量1 153 ml;17例患者均接受输血。手术时间6.5~13.0 h,中位手术时间9.5 h。ICU住院时间2~10 d,中位ICU住院时间5 d。住院时间15~48 d,中位住院时间30 d。围手术期1例死于术后吻合口漏、腹腔感染,其余16例患者均顺利出院。并发症6例,分别为消化道出血3例、腹腔出血1例、胆漏1例、淋巴漏1例。消化道出血患者1例胃镜下止血成功,2例抑酸、止血、禁食水、胃肠减压等保守治疗成功;腹腔出血患者停用抗凝药、对症止血治疗成功;胆漏及淋巴漏患者通畅引流保守治疗成功。16例患者接受随访,截止至投稿日期,6例患者健在,10例死亡。

结论

对于胰腺癌局部晚期患者,根据肿瘤侵犯部位、侵犯范围及程度分型,选择不同的手术方式是安全、可行的。

Objective

To investigate the classification for arterial invasion of pancreatic cancer and the corresponding surgical strategies.

Methods

Clinical data of 17 patients with locally advanced pancreatic cancer admitted to PLA Rocket Force Characteristic Medical Center from July 2021 to May 2024 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 9 patients were male and 8 female, aged from 47 to 71 years,with a median age of 61 years. 13 cases were diagnosed with moderately and poorly differentiated pancreatic adenocarcinoma, 2 cases of pancreatic adenosquamous carcinoma, 1 case of pancreatic ductal adenocarcinoma and 1 case of ampullary adenocarcinoma (pancreaticobiliary type). 10 patients were diagnosed with portal veinsuperior mesenteric vein and superior mesenteric artery invasion, 3 cases of portal vein-superior mesenteric vein and common hepatic artery invasion, 2 cases of portal vein-superior mesenteric vein and proper hepatic artery invasion, and 2 cases of portal vein-superior mesenteric vein and celiac trunk invasion, respectively.According to the arterial invasion sites, all patients were divided into typeⅠ, Ⅱand Ⅲ, and each type was further divided into different subtypes. Perioperative situations such as intraoperative situations, complications and postoperative recovery were observed.

Results

The surgerics of 17 patients were completed successfully.According to different types of arterial invasion of pancreatic cancer, different surgical methods were adopted. Among them, 7 cases were classified as type Ⅰ (3 cases of typeⅠa, 3 cases of type Ⅰb and 1 case of typeⅠd) and 10 cases of typeⅡ. Intraoperative blood loss was 500-3 600 ml, with a median of 1 153 ml.All 17 patients received blood transfusion. The operation time was 6.5-13.0 h, with a median of 9.5 h. The length of ICU stay was 2-10 d, with a median of 5 d. The length of hospital stay was 15-48 d, with a median of 30 d. Perioperatively, 1 patient died of postoperative anastomotic leakage and abdominal infection, and the remaining 16 patients were discharged. 6 cases developed complications, including 3 cases of gastrointestinal bleeding, 1 case of abdominal bleeding, 1 case of bile leakage and 1 case of lymphatic leakage. 1 patient with gastrointestinal bleeding was successfully treated with gastroscopic hemostasis, and 2 patients were treated with conservative treatment such as acid-suppressive therapy, hemostasis, fasting and nasogastric tube decompression, etc. Patients with abdominal bleeding were treated by terminating use of anticoagulants. Those with bile and lymphatic leakage were successfully treated with drainage and conservative treatment. 16 patients were followed up. As of the submission date, 6 patients survived and 10 patients died.

Conclusions

For patients with locally advanced pancreatic cancer, it is safe and feasible to adopted corresponding surgical interventions according to the site, scope and degree of arterial invasion.

图1 胰腺癌动脉受侵分型示意图
图2 胰腺癌动脉受侵不同分型术中图
[1]
Khalaf N, El-Serag HB, Abrams HR, et al. Burden of pancreatic cancer: from epidemiology to practice[J]. Clin Gastroenterol Hepatol,2021, 19(5): 876-884. DOI: 10.1016/j.cgh.2020.02.054.
[2]
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.DOI: 10.3322/caac.21660.
[3]
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J, 2022,135(5): 584-590. DOI: 10.1097/CM9.0000000000002108.
[4]
Kuehn BM. Looking to long-term survivors for improved pancreatic cancer treatment[J]. JAMA, 2020, 324(22): 2242-2244. DOI:10.1001/jama.2020.21717.
[5]
Hackert T, Schneider L, Büchler MW. Current state of vascular resections in pancreatic cancer surgery[J]. Gastroenterol Res Pract,2015, 2015: 120207. DOI: 10.1155/2015/120207.
[6]
de Santibañes M, Pekolj J, Sanchez Claria R, et al. Technical implications for surgical resection in locally advanced pancreatic cancer[J]. Cancers, 2023, 15(5): 1509. DOI: 10.3390/cancers15051509.
[7]
Murakami Y, Nakagawa N, Kondo N, et al. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma[J]. Pancreatology, 2021, 21(3):564-572. DOI: 10.1016/j.pan.2021.01.008.
[8]
Bachellier P, Addeo P, Faitot F, et al. Pancreatectomy with arterial resection for pancreatic adenocarcinoma: how can it be done safely and with which outcomes? A single institution’s experience with 118 patients[J]. Ann Surg, 2020, 271(5): 932-940. DOI: 10.1097/sla.0000000000003010.
[9]
段伟宏, 郭宇, 刘翔, 等. 合并肠系膜上动、静脉同时受侵犯的胰腺癌外科治疗经验[J]. 中华外科杂志, 2022, 60(7): 709-712. DOI:10.3760/cma.j.cn112139-20220413-00161.
[10]
刘军桂, 张涛, 刘翔, 等. 小肠自体移植式扩大胰腺癌根治术的疗效与安全性分析: 附2例报告[J]. 中国普通外科杂志, 2023, 32(9):1296-1304. DOI: 10.7659/j.issn.1005-6947.2023.09.002.Liu JG, Zhang T, Liu X, et al. Analysis of the efficacy and safety of extended radical resection of pancreatic cancer with small bowel autotransplantation: a report of two cases[J]. Chin J Gen Surg, 2023,32(9): 1296-1304. DOI: 10.7659/j.issn.1005-6947.2023.09.002.
[11]
刘军桂, 刘翔, 程波, 等. 胰腺癌肿瘤联合动静脉切除的手术重建方法[J]. 中华胰腺病杂志, 2021, 21(3): 208-210. DOI: 10.3760/cma.j.cn115667-20200804-00122.
[12]
Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration[J]. J Gastrointest Surg,2004, 8(8): 935-950. DOI: 10.1016/j.gassur.2004.09.046.
[13]
Gemici K, Buldu İ, Acar T, et al. Management of patients with retroperitoneal tumors and a review of the literature[J]. World J Surg Oncol, 2015, 13: 143. DOI: 10.1186/s12957-015-0548-z.
[14]
Del Chiaro M, Rangelova E, Halimi A, et al. Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer[J]. HPB, 2019,21(2): 219-225. DOI: 10.1016/j.hpb.2018.07.017.
[15]
Stoop TF, MacKay TM, Brada LJH, et al. Pancreatectomy with arterial resection for periampullary cancer: outcomes after planned or unplanned events in a nationwide, multicentre cohort[J]. Br J Surg,2023, 110(6): 638-642. DOI: 10.1093/bjs/znac353.
[16]
Disclosures. NGP. NCCN Clinical Practice Guidelines in Oncology-Pancreatic Adenocarcinoma(Version2.2023)[EB/OL]. [2024-05-06].http://www.nccn.org/patients.
[17]
Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021, 19(4): 439-457. DOI:10.6004/jnccn.2021.0017.
[18]
Springfeld C, Ferrone CR, Katz MHG, et al. Neoadjuvant therapy for pancreatic cancer[J]. Nat Rev Clin Oncol, 2023, 20(5): 318-337.DOI: 10.1038/s41571-023-00746-1.
[19]
Truty MJ, Kendrick ML, Nagorney DM, et al. Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline/locally advanced pancreatic cancer[J]. Ann Surg, 2021, 273(2): 341-349. DOI: 10.1097/SLA.0000000000003284.
[20]
Truty MJ, Colglazier JJ, Mendes BC, et al. En bloc celiac axis resection for pancreatic cancer: classification of anatomical variants based on tumor extent[J]. J Am Coll Surg, 2020, 231(1): 8-29. DOI:10.1016/j.jamcollsurg.2020.05.005.
[21]
Yoon SJ, Park SJ, Yoon YS, et al. 15-year experience of distal pancreatectomy with celiac axis resection (DP-CAR) for pancreatic cancer-a Korean nationwide investigation[J]. Cancers, 2023, 15(15):3850. DOI: 10.3390/cancers15153850.
[22]
吴国生, 梁廷波. 肿瘤侵犯肠系膜上动脉根治性切除后自体小肠移植行消化道重建的初步思考[J]. 中华外科杂志, 2022, 60(1):27-31. DOI: 10.3760/cma.j.cn112139-20210608-00246.Wu GS, Liang TB. Gastrointestinal reconstruction by intestinal autotransplantation after radical resection of neoplasms involving superior mesenteric artery: a preliminary consideration[J]. Chin J Surg, 2022,60(1): 27-31. DOI: 10.3760/cma.j.cn112139-20210608-00246.
[23]
吴国生, 梁廷波. 自体小肠移植技术的实践与挑战[J]. 中华消化外科杂志, 2021, 20(1): 85-88. DOI: 10.3760/cma.j.cn115610-20201202-00748.Wu GS, Liang TB. Current practice and challenges of intestinal autotransplantation[J]. Chin J Dig Surg, 2021, 20(1): 85-88. DOI:10.3760/cma.j.cn115610-20201202-00748.
[24]
Liang T, Zhang Q, Wu G, et al. Radical resection combined with intestinal autotransplantation for locally advanced pancreatic cancer after neoadjuvant therapy: a report of 36 consecutive cases[J]. Ann Surg, 2023, 278(5): e1055-e1062. DOI: 10.1097/SLA.0000000000005797.
[25]
Zorzetti N, Marino IR, Sorrenti S, et al. Small bowel transplant - novel indications and recent progress[J]. Expert Rev Gastroenterol Hepatol,2023, 17(7): 677-690. DOI: 10.1080/17474124.2023.2221433.
[26]
张涛, 李爱民, 陈道媛, 等. 胰腺全系膜切除技术在胰头癌行胰十二指肠切除术中的应用[J]. 腹部外科, 2018, 31(5): 322-325, 294.DOI: 10.3969/j.issn.1003-5591.2018.05.006.Zhang T, Li AM, Chen DY, et al. Application of total mesopancreas excision technique in pancreaticoduodenectomy for pancreatic head cancer[J]. J Abdom Surg, 2018, 31(5): 322-325, 294. DOI: 10.3969/j.issn.1003-5591.2018.05.006.
[27]
Dunne DFJ, Kleeff J, Yip VS, et al. Arterial resection in pancreatic cancer[M]//Pancreatic Cancer. New York, NY: Springer New York,2018: 1089-1104. DOI: 10.1007/978-1-4939-7193-0_72.
[28]
Loos M, Kester T, Klaiber U, et al. Arterial resection in pancreatic cancer surgery: effective after a learning curve[J]. Ann Surg, 2022,275(4): 759-768. DOI: 10.1097/SLA.0000000000004054.
[29]
Zhao T, Fu Y, Zhang T, et al. Diabetes management in patients undergoing total pancreatectomy: a single center cohort study[J].Front Endocrinol, 2023, 14: 1097139. DOI: 10.3389/fendo.2023.1097139.
[30]
Scholten L, Stoop TF, Del Chiaro M, et al. Systematic review of functional outcome and quality of life after total pancreatectomy[J].Br J Surg, 2019, 106(13): 1735-1746. DOI: 10.1002/bjs.11296.
[1] 冷建军, 朴成林, 司振铎. 胰十二指肠切除术联合小范围肝切除、血管切除重建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 384-384.
[2] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[3] 佘响云, 周小琦, 谢定祥, 陈笑芳, 张印宏, 冯仕庭, 蔡华崧. 磁共振成像与计算机断层扫描在胰腺导管腺癌血管侵犯术前评估中的价值比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(02): 106-110.
[4] 尚培中, 张润萍, 张伟, 贾国洪, 李晓武, 苗建军, 刘冰. 梗阻性黄疸临床防治新技术单中心应用研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 104-107.
[5] 尹泽新, 杨继林, 李有尧, 吴美龙, 刘利平. 肝癌微血管侵犯的术前预测研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 128-134.
[6] 李鑫, 李乐, 陈金明, 刘蕊. 基于Meta 分析构建肝癌微血管侵犯的术前预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 74-80.
[7] 张瑜, 姜梦妮. 基于DWI信号值构建局部进展期胰腺癌放化疗生存获益预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 657-664.
[8] 孟煜凡, 李永政, 樊知遥, 展翰翔. 瘤内微生物在胰腺癌发病和演进中的作用机制及研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 577-582.
[9] 王天福, 王刚. 自身免疫性胰腺炎诊治现状[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 492-497.
[10] 韦德令, 蒋佳君, 徐邦浩, 王继龙, 朱海, 卢婷婷, 张灵, 曾晶晶, 郭雅, 文张. 显微外科肝动脉重建在累及第一肝门胆管癌外科治疗的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 350-356.
[11] 王礼光, 严庆, 廖珊, 符荣党, 陈焕伟. 微血管侵犯及手术切缘对肝细胞癌患者术后生存预后的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 151-157.
[12] 黄金灿, 王迪, 崔松平, 陈晴, 吕少诚, 贺强, 郎韧. 预后营养指数对交界可切除胰腺癌患者术后预后的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 51-56.
[13] 谢井伟, 王森, 王非, 郭永坤. STA-MCA血管搭桥术治疗烟雾病[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 318-320.
[14] 楚海强, 杨远游, 任刚. 胰腺癌放射治疗联合其他治疗方法的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 392-396.
[15] 吴子龙, 吴冰, 袁开盛, 胡瑞翔, 杨华, 王存川. 肥胖与胰腺疾病研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 213-219.
阅读次数
全文


摘要